188 related articles for article (PubMed ID: 6284445)
21. Toxic hepatis during ketoconazole treatment.
Heiberg JK; Svejgaard E
Br Med J (Clin Res Ed); 1981 Sep; 283(6295):825-6. PubMed ID: 6271328
[No Abstract] [Full Text] [Related]
22. Ketoconazole: assessing its risks.
Stern RS
J Am Acad Dermatol; 1982 Apr; 6(4 Pt 1):544. PubMed ID: 6281317
[No Abstract] [Full Text] [Related]
23. Ketoconazole and the liver.
Horseburgh CR; Kirkpatrick CH; Teutsch CB
Lancet; 1982 Apr; 1(8276):860. PubMed ID: 6122089
[No Abstract] [Full Text] [Related]
24. Successful treatment of chronic mucocutaneous candidiasis with ketoconazole.
Rosenblatt HM; Byrne W; Ament ME; Graybill J; Stiehm ER
J Pediatr; 1980 Oct; 97(4):657-60. PubMed ID: 6252309
[TBL] [Abstract][Full Text] [Related]
25. Hepatic toxicity of ketoconazole.
Rollman O; Lööf L
Br J Dermatol; 1983 Mar; 108(3):376-8. PubMed ID: 6299322
[No Abstract] [Full Text] [Related]
26. Treatment of chronic mucocutaneous candidosis with ketoconazole: preliminary results of a controlled, double-blind clinical trial.
Kirkpatrick CH; Petersen EA; Alling DW
Rev Infect Dis; 1980; 2(4):599. PubMed ID: 6255538
[No Abstract] [Full Text] [Related]
27. The treatment of patients with chronic mucocutaneous candidosis and candida onychomycosis with ketoconazole.
Hay RJ; Clayton YM
Clin Exp Dermatol; 1982 Mar; 7(2):155-62. PubMed ID: 6282505
[No Abstract] [Full Text] [Related]
28. Ketoconazole and the antifungals.
Parkin JL
Otolaryngol Head Neck Surg; 1985 Feb; 93(1):132-3. PubMed ID: 3920612
[TBL] [Abstract][Full Text] [Related]
29. Ketoconazole and hepatic reactions.
Boughton K
S Afr Med J; 1983 Jun; 63(25):955. PubMed ID: 6304923
[No Abstract] [Full Text] [Related]
30. [Ketoconazole--a change in antimycotic therapy?].
Meinhof W
Hautarzt; 1983 Apr; 34(4):155-8. PubMed ID: 6303982
[No Abstract] [Full Text] [Related]
31. Oral antifungal therapy. Current status of ketoconazole.
Varkey B
Postgrad Med; 1983 Jan; 73(1):52-3. PubMed ID: 6294644
[TBL] [Abstract][Full Text] [Related]
32. Ketoconazole: a major innovation for treatment of fungal disease.
Graybill JR; Drutz DJ; Murphy AL
Ann Intern Med; 1980 Dec; 93(6):921-3. PubMed ID: 6255850
[No Abstract] [Full Text] [Related]
33. [Ketoconazole].
Cuena Boy R; Azanza Perea JR; Honorato Pérez JM
Rev Med Univ Navarra; 1982 Sep; 26(3):193-4. PubMed ID: 6302808
[No Abstract] [Full Text] [Related]
34. [Chronic mucocutaneous candidiasis].
Wengrower D; Rave D; Kleinman Y
Harefuah; 1986 Sep; 111(5-6):114-6. PubMed ID: 3804055
[No Abstract] [Full Text] [Related]
35. Ketoconazole treatment of chronic mucocutaneous candidiasis.
Montagnani A; Negosanti M; Patrizi A
Drugs Exp Clin Res; 1986; 12(5):409-12. PubMed ID: 3522160
[TBL] [Abstract][Full Text] [Related]
36. Ketoconazole in the treatment of fungal infection. Clinical and laboratory studies.
Hay RJ
Am J Med; 1983 Jan; 74(1B):16-9. PubMed ID: 6295146
[TBL] [Abstract][Full Text] [Related]
37. Treatment of chronic mucocutaneous candidosis with ketoconazole: a study of 12 cases.
Hay RJ; Wells RS; Clayton YM; Wingfield HJ
Rev Infect Dis; 1980; 2(4):600-5. PubMed ID: 6255539
[TBL] [Abstract][Full Text] [Related]
38. Modified response to ketoconazole of Candida albicans from a treatment failure.
Warnock DW; Johnson EM; Richardson MD; Vickers CF
Lancet; 1983 Mar; 1(8325):642-3. PubMed ID: 6131314
[No Abstract] [Full Text] [Related]
39. Chronic mucocutaneous candidiasis treated with ketoconazole (Nizoral).
Daugaard K; Nielsen H; Schiodt M
Tandlaegebladet; 1985 Oct; 89(18):674-8. PubMed ID: 3868177
[No Abstract] [Full Text] [Related]
40. Use of fluconazole in a patient with documented malabsorption of ketoconazole.
Drew RH; Perfect JR; Gallis HA
Clin Pharm; 1988 Aug; 7(8):622-3. PubMed ID: 2844468
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
